Hi everyone, I am asking for some help here. I am currently recording MSN in the striatum brain slice without genetic marker to identify D1-MSN or D2-MSN. I am wondering if there is a pharmacological way I can use to identify D2-MSN while I am recording MSN. Which drug should I use and to test what (Voltage-clamp or Current-clamp measuring what changes)? Thanks!
There are several pharmacological agents that can be used to selectively identify D2-MSNs in the striatum. One commonly used method is to use a dopamine D1 receptor antagonist and a dopamine D2 receptor agonist to differentially modulate the excitability of the two subtypes of MSNs.
Specifically, you can use the D1 receptor antagonist SCH 23390 to block the activity of D1 receptors on D1-MSNs, while leaving the D2 receptors on D2-MSNs intact. At the same time, you can use the D2 receptor agonist quinpirole to selectively activate D2 receptors on D2-MSNs, while leaving the D1 receptors on D1-MSNs unstimulated.
The changes in excitability of D2-MSNs can be measured using either voltage-clamp or current-clamp recordings, depending on the experimental setup and the research question. If you are interested in studying the effects of these pharmacological agents on the synaptic currents or potentials in D2-MSNs, voltage-clamp recordings may be more appropriate. On the other hand, if you are interested in studying the changes in the firing patterns or action potentials of D2-MSNs, current-clamp recordings may be more useful.
In either case, the key is to carefully monitor the effects of SCH 23390 and quinpirole on the activity of the MSNs, and to compare the responses of the neurons to these agents in the presence and absence of the drugs. This will allow you to identify and confirm the identity of D2-MSNs in your recordings.
- Badges
- Science topic
- Similar topics
- Engineering
- Materials Engineering
- Powders